about
Hypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseAdvances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's diseaseToxin-Induced Experimental Models of Learning and Memory ImpairmentAIMP1 downregulation restores chondrogenic characteristics of dedifferentiated/degenerated chondrocytes by enhancing TGF-β signal.Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages.Association of miR-146a, miR-149, miR-196a2, and miR-499 Polymorphisms with Ossification of the Posterior Longitudinal Ligament of the Cervical Spine.Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model.The role of bioactive compounds on the promotion of neurite outgrowth.Promising therapeutics with natural bioactive compounds for improving learning and memory--a review of randomized trials.Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.Traditional Korean East Asian medicines and herbal formulations for cognitive impairment.Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases.Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.Differential regulation of HIF-3α in LPS-induced BV-2 microglial cells: Comparison and characterization with HIF-1α.β-Asarone (cis-2,4,5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells.Anti-neuroinflammatory activity of a novel cannabinoid derivative by inhibiting the NF-κB signaling pathway in lipopolysaccharide-induced BV-2 microglial cells.Molecular effects of activated BV-2 microglia by mitochondrial toxin 1-methyl-4-phenylpyridinium.Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors.Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study.Polymorphisms of miR-146a, miR-149, miR-196a2, and miR-499 are associated with osteoporotic vertebral compression fractures in Korean postmenopausal women.Characterization of active and inactive states of CB1 receptor and the differential binding state modulation by cannabinoid agonists, antagonists and inverse agonists.Matrilin-3 codelivery with adipose-derived mesenchymal stem cells promotes articular cartilage regeneration in a rat osteochondral defect model.Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms.Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.A ratiometric two-photon probe for Ca2+ in live tissues and its application to spinal cord injury model.Corrigendum to "α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease" [Neuropharm 97 (2015) 46-57].Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury.Neutrophil elastase inhibition effectively rescued angiopoietin-1 decrease and inhibits glial scar after spinal cord injuryTRPV4: a Sensor for Homeostasis and Pathological Events in the CNSTherapeutic Efficacy-Potentiated and Diseased Organ-Targeting Nanovesicles Derived from Mesenchymal Stem Cells for Spinal Cord Injury TreatmentNanocarrier-mediated Delivery of CORM-2 Enhances Anti-allodynic and Anti-hyperalgesic Effects of CORM-2Elevated TRPV4 Levels Contribute to Endothelial Damage and Scarring in Experimental Spinal Cord InjuryTargeted Delivery of Mesenchymal Stem Cell-Derived Nanovesicles for Spinal Cord Injury Treatment
P50
Q26778530-C4435ED9-9025-4DF0-A929-2B76CE9CFE88Q26849232-1E86484E-13E3-4D03-96FA-7BC09412CF0EQ27023467-E953CDE0-7A0C-42FB-B337-4944B3F9E470Q28075913-263C6DA9-1B7C-4721-B5FE-D30DA7A83B94Q33586806-5A86FF75-ABB6-413B-BB0C-32A1AB743184Q33860403-87BE509F-458E-4901-ABAD-A6DA49035E98Q36084561-30E1E90E-83A8-423C-B8F5-5181CB77AAB1Q36703085-F9E4393C-E433-48CD-AE62-7A5C901E16D4Q38016042-57073F30-8247-4D3F-A3AA-61858562C70AQ38040287-B4CC39C4-F022-4F78-B564-3698F2975F75Q38046734-E05726F5-1A2A-4394-A2FB-D02D98822E35Q38167279-BFF43471-0947-4D23-BF9D-528EFE98AD74Q38167610-9C1D8281-67B1-4440-9B7B-12B2ADCE97B5Q38837968-A5F0DE87-639C-4C2C-8597-4E9BBCF1B0AEQ38890249-D1E2B0A6-7618-4457-91A6-4A55051DC54FQ38971186-D6ED01B3-B07C-4AC9-AE81-62E90081AAA8Q39201306-B4528926-4650-4397-8CB9-63F4107F7D53Q39405669-9CD422DB-EF15-4873-A80C-6E2C63E5CDB0Q43911427-9D7816C6-8C2F-4F84-A72F-51F610417C32Q45861839-DFE41E5E-A77D-4A9B-AD02-55476BA1D015Q48057150-4A7F27BF-B9D8-4E3E-8B05-28FD8F7C8888Q48278733-8C939704-EC49-4DA4-9CAC-048FB9A1DA0AQ48361434-EA3AA62B-4896-4833-9E0D-178C2589E7A6Q48414886-E7F0F7F8-6255-4EED-82C3-D77CD519D9DAQ50179190-EBFA5ED2-3623-44C9-A1E4-4F55DDFC131AQ50535543-4D523537-36A4-42F0-8863-CB9D1FE9E47EQ53119606-0AC68783-0DDB-42BC-AEE4-656B477CBC96Q54964969-A138A2F4-8902-4716-8B3F-2C0CC9C05C6CQ58798044-1C47DF3C-4C84-4AA9-AEE3-E2EEB904FEBCQ88185369-E4F78C7B-EC41-4866-AD23-69B1A07982EEQ89564888-6B682AE4-D279-4DFB-9339-A2C89D40A8CFQ91022314-0F40BEBE-8AA0-42EE-9625-03A00EC9106AQ92888874-CB85D826-4B52-47D6-968E-AE91FCF84ED0Q96428123-7BCD5FF5-E73F-4EC5-B273-98DAA1704DBB
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6434-0245
@en
name
Hemant Kumar
@ast
Hemant Kumar
@en
Hemant Kumar
@es
Hemant Kumar
@nl
type
label
Hemant Kumar
@ast
Hemant Kumar
@en
Hemant Kumar
@es
Hemant Kumar
@nl
prefLabel
Hemant Kumar
@ast
Hemant Kumar
@en
Hemant Kumar
@es
Hemant Kumar
@nl
P106
P108
P31
P496
0000-0002-6434-0245